This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Morgan Stanley's (MS) Inorganic Expansion Aids Amid High Costs
by Zacks Equity Research
Morgan Stanley's (MS) strategic expansion efforts to focus less on capital markets-driven revenue sources will support profitability. However, rising expenses remain worrisome.
Citigroup (C) Sells Taiwan Consumer Banking Business to DBS
by Zacks Equity Research
Citigroup (C) sells Taiwan consumer banking business to DBS, while retaining its institutional client business there. It expects to get a regulatory capital benefit of $1.2 billion.
Here's Why JPMorgan (JPM) Stock is a Compelling Buy Right Now
by Zacks Equity Research
High interest rates, loan growth, strategic acquisitions, business diversification efforts, strong liquidity position and initiatives to expand in new markets will aid JPMorgan's (JPM) profitability.
Robust AUM Balance Aids SEI Investments (SEIC) Amid Cost Woes
by Zacks Equity Research
A wide range of product offerings, strategic buyouts and a robust AUM balance are likely to drive SEI Investments' (SEIC) top-line growth. Yet, rising costs and exposure to fee-based revenues are concerns.
Wall Street Bulls Look Optimistic About JPMorgan Chase & Co. (JPM): Should You Buy?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in JPMorgan Chase & Co. (JPM). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
JPMorgan Chase & Co. (JPM) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
JPMorgan Chase & Co. (JPM) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
The Zacks Analyst Blog Highlights JPMorgan Chase, Salesforce, Abbott Laboratories, HCA Healthcare and General Motors
by Zacks Equity Research
JPMorgan Chase, Salesforce, Abbott Laboratories, HCA Healthcare and General Motors are included in this Analyst Blog.
Top Stock Reports for JPMorgan Chase, Salesforce & Abbott Laboratories
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase & Co. (JPM), Salesforce, Inc. (CRM) and Abbott Laboratories (ABT).
Why JPMorgan Chase & Co. (JPM) is a Top Stock for the Long-Term
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
Banks Fined by Regulators for Non-Adherence to Record-keeping
by Swayta Shah
Banks like Wells Fargo (WFC), BNP Paribas (BNPQY) and Moelis & Company (MC) face fines totaling $549 million from regulators for failure to maintain proper communication records. This follows similar actions on large banks, including JPM and GS.
Is Vanguard High Dividend Yield ETF (VYM) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for VYM
Stock Market News for Aug 9, 2023
by Zacks Equity Research
U.S. stocks retreated on Tuesday but managed to finish off session lows as concerns grew over the health of U.S. banks and the economy after credit rating agency Moody's downgraded several major lenders and trade data out of China came in disappointing.
JPMorgan (JPM) Strengthens India Presence, Opens Two Offices
by Zacks Equity Research
JPMorgan (JPM) announces the opening of two facilities in Mumbai and Bengaluru.
JPMorgan (JPM) to Expand Presence in Carolinas, Add Branches
by Zacks Equity Research
JPMorgan (JPM) aims to bolster its presence in the Carolinas by having more than 100 branches across both states by 2025.
State Street (STT) Rides on Expansion Efforts Amid Expense Woes
by Zacks Equity Research
Higher rates, inorganic growth strategy and global reach are likely to keep supporting State Street (STT). However, rising expenses and substantial exposure to fee income are major near-term woes.
Dorian and Oxford Industries have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Dorian and Oxford Industries are part of the Zacks Bull and Bear of the Day article.
3 Top Blue Chip Stocks to Ride the Dow Rally
by Tirthankar Chakraborty
As the Dow continues to scale upward, it's prudent to invest in stocks such as JPMorgan (JPM), Walmart (WMT) and Johnson & Johnson (JNJ) that are listed on the said index and are financially sound.
Seeking Stability? 3 Top-Ranked Large-Caps to Buy
by Derek Lewis
While small-caps may boast explosive growth characteristics, the stability of large-caps attracts many. And recently, analysts have become bullish on these three.
Livent and Conagra have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Livent and Conagra have been highlighted as Zacks Bull and Bear of the Day.
Should You Invest in the Vanguard Financials ETF (VFH)?
by Zacks Equity Research
Sector ETF report for VFH
Should You Invest in the iShares U.S. Financials ETF (IYF)?
by Zacks Equity Research
Sector ETF report for IYF
Should Vanguard Russell 1000 Value ETF (VONV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VONV
Market Rally Broadens Out: Banking Giant Hits 52-Week High
by Bryan Hayes
We've heard all year how the rally was being driven solely by big tech, but recent expansion suggests otherwise.
Should You Invest in the iShares U.S. Financial Services ETF (IYG)?
by Zacks Equity Research
Sector ETF report for IYG
5 Picks to Tap Dow's Longest Winning Streak Since 2017
by Sweta Killa
Investors seeking to participate in Dow Jones' longest winning streak since 2017 may consider top-ranked stocks like JPMorgan (JPM), Salesforce (CRM), Caterpillar (CAT), McDonald's (MCD) and Honeywell (HON).